Jefferies Starts Yarrow Bioscience (YARW) at Buy
Bullish initiation with unusually large target-implied upside, tempered by the uncertainty inherent in a single analyst target.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish initiation with unusually large target-implied upside, tempered by the uncertainty inherent in a single analyst target.
What happened, with direct paths to the underlying reporting
Jefferies initiated coverage of YARW with a Buy rating and a $40 target versus a posted price of $18.03, implying about 122% potential upside. This is an analyst opinion and the large implied upside warrants caution.
Target: $40
Posted price: $18.03
Analyst firm: Jefferies
Analyst: Faisal Khurshid
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.